跳至主要内容
临床试验/KCT0002162
KCT0002162招募中未知

Electroacupuncture for treating insomnia in cancer patients: a multicenter, assessor-blinded, randomized controlled, pilot clinical trial

Korea Institute of Oriental Medicine0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 79(Year)(—)
性别
All

入选标准

  • 1. Both male and female, aged 19 or over, but under 80 years
  • 2. The Eastern Cooperative Oncology Group (ECOG) performance status = 2
  • 3. Cessation of cancer-related treatments (e.g. surgery, radiotherapy, chemotherapy, immunotherapy) at least 12 weeks before the trial (except for on-going hormone therapy, which must have been initiated at least 3 weeks prior to enrollment)
  • 4. Continuous insomnia related to cancer treatment or cancer itself for at least 3 months, fulfilment of The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for insomnia disorder
  • 5. Total score in the Insomnia Severity Index (ISI) = 15 points
  • 6. Willingness to participate in the trial and provide written consent

排除标准

  • 1. Current level of sleep disorder even before the diagnosis of cancer
  • 2. Severe anemia (platelet count < 60,000/µL, or hemoglobin < 8 g/dL, or absolute neutrophil count < 1,000)
  • 3. A diagnosis of major depressive disorder, anxiety disorder, panic disorder, or other psychiatric disorders; caffeine, alcohol, or drug addiction; or a subscale of either anxiety or depression in Hamilton Anxiety and Depression Scale (HADS) score = 11 points
  • 4. Level of cancer pain measured by numeric rating scale = 4
  • 5. Six months or less life expectancy
  • 6. A plan of surgery, chemotherapy, radiotherapy during the study
  • 7. A recent change of types or dosages of regular medication in the previous 4 weeks to alleviate insomnia
  • 8. Having taken sleeping pills as required in the previous 2 weeks to alleviate insomnia
  • 9. Having undergone Korean medical treatment (e.g. acupuncture, moxibustion, cupping, herbal medicine, etc.) in the previous 4 weeks
  • 10. Past history in the previous 4 weeks or a new plan during the study of initiating dietary supplements or non-pharmacologic therapies (e.g. cognitive behavioral therapy, exercise etc.) to alleviate insomnia
  • 11. Working shifts or changes in day/night work schedule that could impact circadian rhythm
  • 12. Suffering from pain severe enough to cause sleep disturbance or presence of any disease that could cause insomnia
  • 13. Taking medication for a cardiovascular or hemostatic disorder
  • 14. Abnormal findings in thyroid function test (abnormal level of free thyroxine [free T4] and thyroid stimulating hormone [TSH] < 0.1 uIU/ml or TSH > 5.1 uIU/ml)
  • 15. A previous hypersensitivity reaction to acupuncture or difficulty cooperating with acupuncture therapy
  • 16. The presence of implants that could interfere with electroacupuncture or a history of hypersensitivity to electrostimulation
  • 17. Pregnancy, lactation, or planning a pregnancy
  • 18. Having participated in other clinical trials in the previous 4weeks
  • 19. Difficulty complying with the treatment, questionnaire, or study protocol

研究者

相似试验